Entia Biosciences, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5a45995c-1b6b-434f-86e4-0d97dad6f192/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-1.3M | 2016-01-01 – 2016-12-31 | evidence 0001185185-17-001225 |
| FY 2015 | $-2.0M | 2015-01-01 – 2015-12-31 | evidence 0001185185-16-004208 |
| FY 2014 | $-1.8M | 2014-01-01 – 2014-12-31 | evidence 0001185185-15-000663 |
| FY 2013 | $-3.0M | 2013-01-01 – 2013-12-31 | evidence 0001469709-14-000106 |
| FY 2012 | $-1.1M | 2012-01-01 – 2012-12-31 | evidence 0001469709-13-000163 |
| FY 2011 | $-1.5M | 2011-01-01 – 2011-12-31 | evidence 0001469709-12-000060 |
| FY 2010 | $-1.0M | 2010-01-01 – 2010-12-31 | evidence 0001469709-12-000060 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).